City

Bethesda (1)

Condition

Alopecia Areata (1)

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

ruxolitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of

Recruiting

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
Alopecia Areata

Ruxolitinib

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 17, 2022